Does Entry Remedy Collusion? Evidence from the Generic Prescription Drug Cartel
Year of publication: |
March 2022
|
---|---|
Authors: | Starc, Amanda ; Wollmann, Thomas G. |
Institutions: | National Bureau of Economic Research (issuing body) |
Publisher: |
Cambridge, Mass : National Bureau of Economic Research |
Subject: | Wettbewerbsbeschränkung | Restraints of competition | Preiskartell | Price-fixing cartel | Pharmaindustrie | Pharmaceutical industry | Generika | Generic drugs | Markteintritt | Market entry | Preiswettbewerb | Price competition | USA | United States |
Extent: | 1 Online-Ressource illustrations (black and white) |
---|---|
Series: | NBER working paper series ; no. w29886 |
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Arbeitspapier ; Working Paper ; Graue Literatur ; Non-commercial literature |
Language: | English |
Notes: | Hardcopy version available to institutional subscribers |
Other identifiers: | 10.3386/w29886 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Langguth, Juliane, (2018)
-
Olson, Luke M., (2013)
-
Generic competition and price regulation in pharmaceuticals : evidence from the European Union
Tuncay, Berna, (2020)
- More ...
-
A New Era of Midnight Mergers : Antitrust Risk and Investor Disclosures
Barrios, John M., (2022)
-
How to Get Away with Merger : Stealth Consolidation and Its Real Effects on US Healthcare
Wollmann, Thomas G., (2020)
-
From Revolving Doors to Regulatory Capture? Evidence from Patent Examiners
Tabakovic, Haris, (2018)
- More ...